MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 196 filers reported holding MEDICINES CO in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,306,000 | +40.6% | 70,000 | +16.7% | 1.52% | +42.0% |
| Q4 2017 | $1,640,000 | -77.9% | 60,000 | -70.0% | 1.07% | -47.7% |
| Q3 2017 | $7,408,000 | +29.9% | 200,000 | +33.3% | 2.04% | -36.6% |
| Q2 2017 | $5,702,000 | -53.4% | 150,000 | -40.0% | 3.22% | -46.7% |
| Q1 2017 | $12,225,000 | +31.0% | 250,000 | -9.1% | 6.05% | +8.4% |
| Q4 2016 | $9,334,000 | -38.2% | 275,000 | -31.2% | 5.58% | +107.3% |
| Q3 2016 | $15,096,000 | +648.1% | 400,000 | +566.7% | 2.69% | +227.8% |
| Q2 2016 | $2,018,000 | – | 60,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
| Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
| BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
| HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
| Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
| Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
| Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
| Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
| DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
| Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |